Skip to main content

Hospital & Laboratory

bioMérieux aims to advance the impact of Clinical Diagnostic in Healthcare by effectively developing and delivering to the market innovative solutions that address significant unmet operational and medical needs, contributing to fight the rise of antimicrobial resistance and to better manage acute conditions linked to infections.

We develop equipment, tests and software that deliver rapid, high-impact, actionable results in immunoassays, microbiology and molecular biology.

Thanks to our "solutions" approach, we take care to always put the patient's interest first by providing our customers with increasingly integrated solutions for optimal workflow and time to result.

In Hospital / In Lab

Patient Conditions 

Antimicrobial Resistance

Antimicrobial Resistance is undermining modern medicine and putting patients at risk of premature death. bioMérieux is committed to preserving antibiotic efficacy with the right diagnostic tests that guide appropriate and responsible use of antibiotics to ensure they remain lifesaving for posterity.

COVID-19/SARS-CoV-2

Because every COVID-19 patient comes with a unique profile and experiences the disease differently, patient management means asking the right questions, finding the right answers and providing appropriate care the entire length of the patient pathway.

Sepsis Solutions 

Early detection and specific clinical intervention has been shown to be crucial for the improved outcome of patients with sepsis. However, sepsis can be difficult to distinguish from other, non-infectious conditions in critically ill patients. bioMérieux provides solutions to help clinicians diagnose and assess sepsis risk as quickly and accurately as possible.

Speciality 

Connectivity and Data

Decision-making can be based on facts and figures that are easily available when needed, to measurably improve the quality, safety, efficiency, and cost of patient care.

Total Service Solutions

At bioMérieux, we understand that ongoing management of a diagnostics platform in the clinical laboratory or in clinic-based settings is no mean feat. That’s why we aim to provide easy access to information and resources to help customers use our products and services with confidence.

Products

Clear All
  • EMAG® 

    Nucleic Acid Extraction System

    EMAG® offers efficient and flexible extraction to manage both routine and challenging customer needs, supported by a committed and skilled team at bioMérieux.

  • ESTREAM®

    Automated PCR Setup

    ESTREAM® offers high-precision automated PCR setup for streamlined workflow and secured results.

  • ETEST®

    Antibiotic Susceptibility Testing Reagent Strips to Determine On-Scale MICs

    Clinicians often need more information than what primary AST can provide. Recognized around the world for their proven performance, ETEST® ready to use reagent strips determine on-scale MICs.

  • ETEST®  ERAVACYCLINE

    ETEST Eravacycline provides a flexible diagnostic solution for multi-drug resistant Gram-negative and Gram-positive organisms.

  • ETEST®  IMIPENEM/ RELEBACTAM

     ETEST Imipenem/Relebactam provides an additional diagnostic solution for multi-drug resistant Gram-negative organisms and helps clinicians guide and manage therapy.

  • ETEST® Ceftazidime/ Avibactam

    For accurate and rapid antimicrobial susceptibility testing for ceftazidime/avibactam, there’s  ETEST Ceftazidime/Avibactam. 

  • ETEST® Ceftolozane Tazobactam

    ETEST generates MIC values from a continuous scale and can give results between conventional two-fold dilutions, i.e., half dilutions. 

  • ETEST® DELAFLOXACIN

    ETEST Delafloxacin provides an additional diagnostic solution to help support antimicrobial stewardship initiatives.

  • ETEST® Meropenem/vaborbactam

    ETEST Meropenem/vaborbactam provides an additional treatment solution for multi-drug resistant Gram-negative organisms and helps clinicians guide and manage therapy.

  • ETEST® PIPERACILLIN/TAZOBACTAM

    ETEST piperacillin/tazobactam provides an additional treatment solution for multi-drug resistant Gram-negative organisms and helps clinicians guide and manage therapy.

  • ETEST® PLAZOMICIN

    ETEST Plazomicin is part of an integrated ID/AST offer to help complete your AST pathway and support your antimicrobial stewardship initiatives.

  • ETEST® Telavancin

    ETEST® Telavancin is a quantitative technique for determining the susceptibility of Staphylococcus aureus (including methicillin resistant S. aureus).

  • MAESTRIA™

    New Generation Microbiology Middleware

    An innovative, integrated software solution designed to orchestrate your lab routine and transform data into insights.

  • MYLA®

    Due to its robust connectivity to bioMérieux equipment, MYLA allows lab results to be collected, consolidated, and communicated to stakeholders in real-time.

  • NTM Elite agar

    The NTM Elite agar plate is the industrial version of the RGM medium. It enables easier and improved diagnosis compared to commonly used Acid-Fast Bacilli (AFB) culture media.

  • NUCLISENS®easyMAG®

    NUCLISENS easyMAG is an IVD-labeled automated system for total nucleic acid extraction from a variety of sample types and volumes. 

  • PREVI® COLOR GRAM

    A Market-Leading Automated Gram Stainer Offering Confidence in Results

    Gram staining is a key step in your microbiology workflow, and PREVI® COLOR GRAM is the system to streamline it and provide timely staining results for impactful decisions.

  • RAPIDEC® CARBA NP

    Rapid, Reliable Test for Carbapenemase-Producing Bacteria

    This test gives reliable results in under 2 hours, making it the quick and easy way to control carbapenemase producers and meet diagnostic and screening challenges, improve patient management, and control healthcare associated infections.

  • VIDAS® 3

    Trusted. Robust. Innovative.

    With its advanced immunoassay technology and optimized testing protocols, the fully automated VIDAS® 3 benchtop immunoanalyzer empowers your lab with confidence, offering the precise results you need, when you need them. 

  • VIDAS® C. difficile GDH & TOXIN A & B

    The VIDAS® C. difficile GDH and TOXIN A & B (CDAB) are two complementary tests used as an aid in the diagnosis of C. difficile associated disease.